Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies  
Schedule of single segment's significant expenses in consistent with Company's consolidated statement of operations and comprehensive loss

Three Months Ended

March 31,

Single Reportable Segment

2026

2025

U3O8 sales

3,904

Disposal fees

27

Sales

3,931

U3O8 product costs

2,687

Lower of cost or NRV adjustments

2,598

Cost of sales

2,687

2,598

Gross profit (loss)

1,244

(2,598)

Exploration and evaluation

2,279

1,044

Development

14,946

9,743

General and administration

3,923

2,173

Accretion of asset retirement obligations

429

277

Operating costs

21,577

13,237

Operating profit (loss)

(20,333)

(15,835)

Interest income

765

867

Interest expense

(2,946)

(266)

Mark to market gain (loss)

(6,363)

4,310

Foreign exchange gain (loss)

(639)

Other income (loss)

741

26

Net income (loss)

(28,775)

(10,898)

Schedule of financial assets and liabilities measured at fair value on recurring basis

Fair Value Hierarchy as of March 31, 2026

Fair Value Hierarchy as of December 31, 2025

Level 1

Level 2

Level 3

Total

Level 1

Level 2

Level 3

Total

Financial instrument assets

Cash equivalents

83,395

83,395

2,938

2,938

Marketable securities

412

412

Restricted cash equivalents

12,790

12,790

11,472

11,472

Capped call derivative

16,288

16,288

15,108

15,108

96,597

16,288

112,885

14,410

15,108

29,518

Financial instrument liabilities

Inventory derivative
obligation (net)

17,313

17,313

16,638

16,638

Warrant liability

1,541

1,541

Stock option liabilities

1,719

1,719

1,346

1,346

Conversion option derivative

56,192

56,192

52,258

52,258

19,032

56,192

75,224

19,525

52,258

71,783